SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country
5 references·0 citing·20 second hop
Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country (2019)Safe-Testing Algorithm for Individual-Don…Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes (2018)Assessment of HIV transfusion…The current status of nucleic acid amplification technology in transfusion‐transmitted infectious disease testing (2016)The current status of nucleic…Prevalence of human immunodeficiency virus RNA and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios (2013)Prevalence of human immunodef…International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)International survey on NAT t…Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus? (2008)Blood donor screening: how to…Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)Mini‐pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results (1998)Residual Risk of Hepatitis-B-Infected Blood Donations: Estimation Methods and Perspectives (2013)Seroprevalence of hepatitis B and hepatitis C viral infections among blood donors of Central Karnataka, India (2013)Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and Treponema pallidum (2022)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations (2017)Use of Blood Donor Screening to Monitor Prevalence of HIV and Hepatitis B and C Viruses, South Africa (2017)HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men (2020)Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions (2009)Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Effect of HIV pre‐exposure prophylaxis (PrEP) on detection of early infection and its impact on the appropriate post‐PrEP deferral period (2020)The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France (2020)Robust possibilistic programming to design a closed-loop blood supply chain network considering service-level maximization and lateral resupply (2022)
this work references cited by second hop

References

  • 2011International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009191 cited
  • 2018Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes55 cited
  • 2013Prevalence of human immunodeficiency virus RNA and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios50 cited
  • 2008Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?47 cited
  • 2016The current status of nucleic acid amplification technology in transfusion‐transmitted infectious disease testing8 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work